It’s a Great Time to Buy Closed-End Funds, IF You Know What You’re Doing
CEFs Take a 180-Degree Turn
Rights Offering Extended, a Fund Repels an Activist, and More...
CEFs Suffer a Terrible, Horrible, No Good, Very Bad Week
A Saba vs. GIM Soap Opera, Two Term Funds Propose Going Perpetual, and More...
Back to 2022 Normal
An Activist Takeover, Merger Completed, Several Leverage and Distribution Changes, and More...
Finally, a "Normal" Week
See all

Taggart's Closed-End Fund Report